MDT
89.64
-0.03%↓
VEEV
281.99
+1.94%↑
A
113.98
-2.16%↓
WBA
11.48
-0.26%↓
HQY
97.59
-2.48%↓
MDT
89.64
-0.03%↓
VEEV
281.99
+1.94%↑
A
113.98
-2.16%↓
WBA
11.48
-0.26%↓
HQY
97.59
-2.48%↓
MDT
89.64
-0.03%↓
VEEV
281.99
+1.94%↑
A
113.98
-2.16%↓
WBA
11.48
-0.26%↓
HQY
97.59
-2.48%↓
MDT
89.64
-0.03%↓
VEEV
281.99
+1.94%↑
A
113.98
-2.16%↓
WBA
11.48
-0.26%↓
HQY
97.59
-2.48%↓
MDT
89.64
-0.03%↓
VEEV
281.99
+1.94%↑
A
113.98
-2.16%↓
WBA
11.48
-0.26%↓
HQY
97.59
-2.48%↓
24h
Current
Min
17.98
Max
19.3
Recommendations | Buy |
---|---|
12 Months Forecast | +55.44% upside |
Next Earnings | 6 sie 2025 |
---|
By Acuity
15%
85%
21 / 376 Ranking in Healthcare
By Trading Central
Confidence
Neutral Evidence
11.39 / 14.13 Support & Resistance
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
19 gru 2024, 15:25 UTC
Assembly Biosciences Shares Rise 19% After Gilead Investment, Funding
DJ
Read
19 gru 2024, 13:38 UTC
Assembly Biosciences Gets $30.1 Million Equity Investment, Funding From Gilead
DJ
Read
29 gru 2024, 08:00 UTC
Gilead Buys $20.1 Million of Assembly Biosciences Stock -- Barrons.com
DJ
Read
19 gru 2024, 13:23 UTC
Assembly Biosciences Gets $30.1M Equity Investment, Funding From Gilead
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 30 USD 55.44%
High 31 USD
Low 29 USD
Based on 2 Wall Street analysts offering 12 month price targets forAssembly Biosciences Inc - Dist in the last 3 months.
By TipRanks
Buy
2 ratings
2
Buy
0
Hold
0
Sell
Based on 2 analysts giving stock ratings to Assembly Biosciences Inc - Dist in the past 3 months.
By Trading Central
Short Term
Neutral Evidence
The bullish and bearish events are balanced.
Intermediate Term
Strong Bullish Evidence
Recent bullish events outweigh bearish events.
Long Term
Bearish Evidence
All events are bearish.
By Acuity
News Sentiment
Very Strong Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
$